Status:
COMPLETED
ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
Zuercher Hoehenklinik Wald
Hocoma AG, Switzerland
Conditions:
Stroke
Spinal Cord Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Early verticalization and stepping with the equipment of Hocoma ERIGO during monitoring of vital parameters. The device is already CE marked and, for the purposes of the study, will be used in accorda...
Detailed Description
In early rehabilitation of neurological patients, safe mobilization and intensive sensorimotor stimulation are key factors for therapeutic success. Early activation and stimulation of the patient inte...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- minimum 18 years old
- normal response to verbal instructions
- oxygen saturation of the blood at least 92%
- healthy german speaking men and women
- non-smoker
- heartbeat 40-100
- systolic blood pressure 120 to 220 mmHg
- in patients: post acute phase: stroke or other neurological functional disorder
- Exclusion criteria:
- severe contraction in the legs (Ashworth \>3)
- pregnancy
- acute pain syndrome
- severe cardio-pulmonary disease
- history of orthostatic dysregulation
- thrombophlebitis
- diabetes
- renal disease
- contraindication for electric stimulation (instable epilepsy, cancer, pacemaker, palliative care)
- weight \> 120kg
- height \> 210 cm
- skin lesions on legs
Exclusion
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02268266
Start Date
April 1 2010
End Date
March 1 2015
Last Update
November 18 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zürcher Höhenklinik Wald
Wald, Canton of Zurich, Switzerland, 8636
2
ETH Zurich
Zurich, Canton of Zurich, Switzerland, 8091